| UniProt ID | F10C1_HUMAN | |
|---|---|---|
| UniProt AC | Q70Z53 | |
| Protein Name | Protein FRA10AC1 | |
| Gene Name | FRA10AC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 315 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | ||
| Protein Sequence | MHGHGGYDSDFSDDERCGESSKRKKRTVEDDLLLQKPFQKEKHGKVAHKQVAAELLDREEARNRRFHLIAMDAYQRHTKFVNDYILYYGGKKEDFKRLGENDKTDLDVIRENHRFLWNEEDEMDMTWEKRLAKKYYDKLFKEYCIADLSKYKENKFGFRWRVEKEVISGKGQFFCGNKYCDKKEGLKSWEVNFGYIEHGEKRNALVKLRLCQECSIKLNFHHRRKEIKSKKRKDKTKKDCEESSHKKSRLSSAEEASKKKDKGHSSSKKSEDSLLRNSDEEESASESELWKGPLPETDEKSQEEEFDEYFQDLFL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MHGHGGYD -------CCCCCCCC | 8.46 | 19413330 | |
| 7 | Phosphorylation | -MHGHGGYDSDFSDD -CCCCCCCCCCCCCC | 19.50 | 33259812 | |
| 9 | Phosphorylation | HGHGGYDSDFSDDER CCCCCCCCCCCCCCC | 31.88 | 22617229 | |
| 12 | Phosphorylation | GGYDSDFSDDERCGE CCCCCCCCCCCCCCC | 49.49 | 22617229 | |
| 20 | Phosphorylation | DDERCGESSKRKKRT CCCCCCCCCCCCCCC | 26.83 | 26074081 | |
| 21 | Phosphorylation | DERCGESSKRKKRTV CCCCCCCCCCCCCCH | 31.98 | 26074081 | |
| 36 | Acetylation | EDDLLLQKPFQKEKH HHHHHHCCCCCCCCC | 48.01 | 23954790 | |
| 36 | Sumoylation | EDDLLLQKPFQKEKH HHHHHHCCCCCCCCC | 48.01 | - | |
| 36 | Ubiquitination | EDDLLLQKPFQKEKH HHHHHHCCCCCCCCC | 48.01 | 29967540 | |
| 40 | Acetylation | LLQKPFQKEKHGKVA HHCCCCCCCCCCCCC | 69.94 | 19820223 | |
| 42 | Acetylation | QKPFQKEKHGKVAHK CCCCCCCCCCCCCHH | 65.77 | 19820231 | |
| 42 | Ubiquitination | QKPFQKEKHGKVAHK CCCCCCCCCCCCCHH | 65.77 | - | |
| 45 | Acetylation | FQKEKHGKVAHKQVA CCCCCCCCCCHHHHH | 35.65 | 19820239 | |
| 49 | Acetylation | KHGKVAHKQVAAELL CCCCCCHHHHHHHHH | 36.41 | 25953088 | |
| 58 | Methylation | VAAELLDREEARNRR HHHHHHCHHHHHHCC | 43.56 | - | |
| 84 | Phosphorylation | HTKFVNDYILYYGGK HHHHHHCEEEEECCC | 6.39 | - | |
| 88 | Phosphorylation | VNDYILYYGGKKEDF HHCEEEEECCCHHHH | 18.89 | - | |
| 92 | Acetylation | ILYYGGKKEDFKRLG EEEECCCHHHHHHHC | 66.83 | 18584541 | |
| 103 | Ubiquitination | KRLGENDKTDLDVIR HHHCCCCCCCHHHHH | 56.36 | 24816145 | |
| 110 | Ubiquitination | KTDLDVIRENHRFLW CCCHHHHHHCCCCCC | 38.21 | 24816145 | |
| 150 | Ubiquitination | YCIADLSKYKENKFG HHHHHHHHHCCCCCC | 68.58 | 29967540 | |
| 178 | Acetylation | GQFFCGNKYCDKKEG CEEECCCCCCCCCCC | 32.32 | 25953088 | |
| 178 | Ubiquitination | GQFFCGNKYCDKKEG CEEECCCCCCCCCCC | 32.32 | 29967540 | |
| 201 | Acetylation | GYIEHGEKRNALVKL EEECCHHHHCHHHHH | 56.39 | 25953088 | |
| 248 | Phosphorylation | EESSHKKSRLSSAEE HHHHHHHHHHHHHHH | 43.17 | 25106551 | |
| 251 (in isoform 5) | Phosphorylation | - | 26.79 | - | |
| 251 (in isoform 2) | Phosphorylation | - | 26.79 | - | |
| 251 (in isoform 4) | Phosphorylation | - | 26.79 | - | |
| 251 (in isoform 3) | Phosphorylation | - | 26.79 | - | |
| 251 | Phosphorylation | SHKKSRLSSAEEASK HHHHHHHHHHHHHHH | 26.79 | 25159151 | |
| 252 (in isoform 4) | Phosphorylation | - | 44.27 | - | |
| 252 (in isoform 5) | Phosphorylation | - | 44.27 | - | |
| 252 (in isoform 2) | Phosphorylation | - | 44.27 | - | |
| 252 (in isoform 3) | Phosphorylation | - | 44.27 | - | |
| 252 | Phosphorylation | HKKSRLSSAEEASKK HHHHHHHHHHHHHHH | 44.27 | 25159151 | |
| 257 | Phosphorylation | LSSAEEASKKKDKGH HHHHHHHHHHHCCCC | 48.57 | 29396449 | |
| 259 | Acetylation | SAEEASKKKDKGHSS HHHHHHHHHCCCCCC | 64.80 | 26051181 | |
| 260 | Acetylation | AEEASKKKDKGHSSS HHHHHHHHCCCCCCC | 69.29 | 26051181 | |
| 266 | Phosphorylation | KKDKGHSSSKKSEDS HHCCCCCCCCCHHHH | 40.27 | 27282143 | |
| 267 | Phosphorylation | KDKGHSSSKKSEDSL HCCCCCCCCCHHHHH | 47.30 | 27282143 | |
| 269 | Acetylation | KGHSSSKKSEDSLLR CCCCCCCCHHHHHHH | 62.11 | 19806579 | |
| 270 (in isoform 3) | Phosphorylation | - | 50.82 | 26437602 | |
| 270 | Phosphorylation | GHSSSKKSEDSLLRN CCCCCCCHHHHHHHC | 50.82 | 22617229 | |
| 273 | Phosphorylation | SSKKSEDSLLRNSDE CCCCHHHHHHHCCCC | 25.83 | 30266825 | |
| 273 (in isoform 3) | Phosphorylation | - | 25.83 | 26437602 | |
| 278 | Phosphorylation | EDSLLRNSDEEESAS HHHHHHCCCCHHHCC | 39.71 | 23927012 | |
| 283 | Phosphorylation | RNSDEEESASESELW HCCCCHHHCCHHHHH | 40.13 | 23927012 | |
| 285 | Phosphorylation | SDEEESASESELWKG CCCHHHCCHHHHHCC | 51.43 | 23927012 | |
| 287 | Phosphorylation | EEESASESELWKGPL CHHHCCHHHHHCCCC | 35.18 | 23927012 | |
| 291 (in isoform 5) | Phosphorylation | - | 64.37 | 26552605 | |
| 294 (in isoform 5) | Phosphorylation | - | 9.02 | 26552605 | |
| 297 | Phosphorylation | WKGPLPETDEKSQEE HCCCCCCCCCHHHHH | 47.74 | 27732954 | |
| 299 (in isoform 5) | Phosphorylation | - | 63.13 | 26552605 | |
| 301 | Phosphorylation | LPETDEKSQEEEFDE CCCCCCHHHHHHHHH | 40.55 | 27732954 | |
| 303 (in isoform 5) | Phosphorylation | - | 67.59 | 26552605 | |
| 307 (in isoform 5) | Phosphorylation | - | 53.63 | 26552605 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of F10C1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F10C1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F10C1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ARHL2_HUMAN | ADPRHL2 | physical | 16169070 | |
| CG025_HUMAN | C7orf25 | physical | 16169070 | |
| GDPD2_HUMAN | GDPD2 | physical | 16169070 | |
| PLPR4_HUMAN | LPPR4 | physical | 16169070 | |
| GLRX3_HUMAN | GLRX3 | physical | 16169070 | |
| VPS29_HUMAN | VPS29 | physical | 16169070 | |
| EF1D_HUMAN | EEF1D | physical | 16169070 | |
| PR40A_HUMAN | PRPF40A | physical | 22365833 | |
| SF3B2_HUMAN | SF3B2 | physical | 22365833 | |
| U2AF1_HUMAN | U2AF1 | physical | 22365833 | |
| CHERP_HUMAN | CHERP | physical | 22365833 | |
| PRPF3_HUMAN | PRPF3 | physical | 22365833 | |
| MFAP1_HUMAN | MFAP1 | physical | 22365833 | |
| RED_HUMAN | IK | physical | 22365833 | |
| THOC1_HUMAN | THOC1 | physical | 22365833 | |
| CWC27_HUMAN | CWC27 | physical | 22365833 | |
| DGC14_HUMAN | DGCR14 | physical | 22365833 | |
| ZN830_HUMAN | ZNF830 | physical | 22365833 | |
| S30BP_HUMAN | SAP30BP | physical | 22365833 | |
| NKAP_HUMAN | NKAP | physical | 22365833 | |
| TTC14_HUMAN | TTC14 | physical | 22365833 | |
| ZCH10_HUMAN | ZCCHC10 | physical | 22365833 | |
| M3K12_HUMAN | MAP3K12 | physical | 16169070 | |
| KASH5_HUMAN | CCDC155 | physical | 25416956 | |
| CLIC1_HUMAN | CLIC1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-9; SER-12; SER-278 AND SER-283, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-9; SER-12; SER-278 AND SER-283, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251 AND SER-252, ANDMASS SPECTROMETRY. | |